Scripps Green Hospital Hematology and Medical Oncology

Topics

• Chronic Lymphocytic Leukemia Research 82
• CAR-T cell therapy research 33
• Cancer Immunotherapy and Biomarkers 22
• Hematopoietic Stem Cell Transplantation 21
• Lymphoma Diagnosis and Treatment 21
• Lung Cancer Treatments and Mutations 16
• Acute Myeloid Leukemia Research 14
• Neutropenia and Cancer Infections 10
• Brain Metastases and Treatment 8
• Chronic Myeloid Leukemia Treatments 8
• Glioma Diagnosis and Treatment 8
• Multiple Myeloma Research and Treatments 8

Most cited

1. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 1,863 citations · Kathryn Bollin

2. KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study.

   Lancet (London, England) · 2021 · 704 citations · Dimitrios Tzachanis

3. Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults.

   The New England journal of medicine · 2024 · 235 citations · Dimitrios Tzachanis

4. SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade.

   Nature · 2025 · 104 citations · Jacob New

5. Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 364 citations · Kathryn Bollin

6. Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study.

   Blood · 2021 · 295 citations · Levanto Schachter